Oruka Therapeutics, Inc. ORKA Deferred Tax Liabilities Right Of Use Asset
Deferred Tax Liabilities Right Of Use Asset at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept orka:DeferredTaxLiabilitiesRightOfUseAsset.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s deferred tax liabilities right of use asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s deferred tax liabilities right of use asset?
- Oruka Therapeutics, Inc. (ORKA) reported deferred tax liabilities right of use asset of $424K in Q4 2025.
- What does deferred tax liabilities right of use asset mean?
- This represents the deferred tax liability created by the temporary difference between the carrying amount of right-of-use assets under lease accounting standards and their corresponding tax base. It indicates the future tax consequences associated with the company's leased assets. This metric is essential for evaluating the tax-related obligations stemming from the company's operational footprint.